-logo-1200x675.png?v=20261007110104)
What happened
The Procter & Gamble Company (NYSE: PG) reported first-quarter fiscal 2027 net sales of $23.3 billion on October 22, 2026. Organic sales rose 4%. Diluted net earnings per share were $1.97, and core EPS was $2.00. The company returned $3.9 billion to shareowners. Operating cash flow was $5.8 billion for the quarter. Reported net earnings were $4.8 billion, and free cash flow was $4.4 billion for the quarter.
The company also raised all-in fiscal 2027 sales growth guidance to 2% to 4% because of Thorne. It kept its other outlooks in place.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Net sales | $23.3 billion | from $22.4 billion, +4.0% | SEC 8-K earnings release |
| Diluted EPS | $1.97 | from $1.95, +1% | SEC 8-K earnings release |
| Core EPS | $2.00 | from $1.99, +1% | SEC 8-K earnings release |
| Operating cash flow | $5.8 billion | SEC 8-K earnings release | |
| Gross margin | 49.8% | from 51.4%, -160 basis points | SEC 8-K earnings release |
| Cash returned to shareowners | $3.9 billion | SEC 8-K earnings release |
Why it matters
Net sales rose $0.9 billion from $22.4 billion a year earlier. Organic sales increased 4%, helped by a 2% volume increase and 1% favorable mix. Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine Family Care all posted organic growth.
OptimistFi's case is that Procter & Gamble turns scale and brand strength into predictable cash flow, dividends and buybacks. This filing supports that view with 93% free cash flow productivity and $3.9 billion returned to shareowners.
The quarter also shows growth under cost pressure. Reported gross margin fell 160 basis points and operating margin fell 70 basis points. Diluted EPS rose 1%, so the quarter was not a clean operating win.
The sales gain still matters because the company kept its organic sales, EPS growth and cash-return guidance in place. It did not reset the core outlook.
Stock perps: every US stock that trades as a perpetual future, by leverage, live
What's next
Fiscal 2027 still calls for organic sales growth of 1% to 3%, diluted EPS growth of 1% to 5% and core EPS growth in-line to 3%. The company also expects free cash flow productivity of 85% to 90%, dividends above $10 billion, about $5 billion of share repurchases and a core effective tax rate of 20% to 21%. Results inside those ranges would support the case. Another margin step down would weaken it.
More from OptimistFi
- PG stock: the The Procter & Gamble thesis, its status and the next test to watch
- Stock research on every company OptimistFi covers
From OptimistFi Perps
- Top perps movers today: stocks, commodities, FX and indices
- Open interest live: crypto and stock perps by exchange
- All perp markets: price, open interest and funding by venue
- Futures calculator: liquidation price, PnL and fees by exchange
- Perp funding rates live: what longs and shorts pay on every venue
Sources
- SEC 8-K exhibit 99.1 news release — October 22, 2026 earnings release
- SEC 8-K — Form 8-K filed October 22, 2026
Read the full OptimistFi thesis on The Procter & Gamble Company: https://optimistfi.com/stocks/PG
See what would break the The Procter & Gamble Company thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full The Procter & Gamble Company investment case, its status and the next test to watch live on the The Procter & Gamble Company thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
